Pharmacyclics LLC / Janssen
Verified Pharmaceutical Manufacturer & Oncology Drug Supplier
Pharmacyclics LLC / Janssen
Verified PartnerRegistered pharmaceutical manufacturer and healthcare technology supplier listed on the ONC-ORG national directory.
Company Profile & Registration
Legal Organization NamePharmacyclics LLC / Janssen
Manufacturer Identification CodeRegistered
Authorized RepresentativeCorporate Representative
Compliance & StatusActive / Listed
Oncology Drugs & Clinical Formulations
Featured Drug Formulation
View Complete Drug Profile Imbruvica
Generic: ibrutinib
Class: Bruton's Tyrosine Kinase (BTK) Inhibitor
Indications: Adult patients with chronic lymphocytic leukemia (CLL) / small lymphocytic lymphoma (SLL), Waldenström's macroglobulinemia, and chronic graft-versus-host disease (cGVHD) after failure of one or more lines of systemic therapy.
Direct Communication & Assistance
Send an Inquiry to Pharmacyclics LLC / Janssen
Our oncology navigation desk will route your inquiry regarding medicine access, clinical partnerships, or product availability to the appropriate representative.
